Overview

Sex-Specific Effects of Endocrine Disruption on Aging and Alzheimer's Disease

Status:
Recruiting
Trial end date:
2023-05-01
Target enrollment:
Participant gender:
Summary
The researchers are trying to determine whether ovarian hormones are associated with aging processes and with the risk of developing Alzheimer's disease in women.
Phase:
Phase 4
Details
Lead Sponsor:
Mayo Clinic
Collaborator:
National Institute on Aging (NIA)
Treatments:
Corticosterone